Question 1

What is Bo-Seong Jeong?

Accepted Answer

Bo-Seong Jeong is a Person.

Question 2

How often does Bo-Seong Jeong appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 6 articles.

Question 3

When was Bo-Seong Jeong first tracked by Ergen?

Accepted Answer

First tracked on Jul 23, 2026.

Question 4

When was Bo-Seong Jeong last mentioned in news?

Accepted Answer

Last active on Jul 27, 2026.

Question 5

What is Bo-Seong Jeong's current news sentiment?

Accepted Answer

Aggregate sentiment score: 30 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Bo-Seong Jeong in global news coverage?

Accepted Answer

Attention score of 3, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Bo-Seong Jeong?

Accepted Answer

KAIST develops TCR-like antibody targeting KRAS G12D (Jul 23, 2026, 6 articles).

Question 8

How did the "KAIST develops TCR-like antibody targeting KRAS G12D" event impact Bo-Seong Jeong?

Accepted Answer

Bo-Seong Jeong co-led the study as Head of Research at Therazyne, playing a key role in the research.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.